Form 4: Surgery Partners Executive Jennifer Baldock Reports Acquisition of Restricted Stock

Jennifer Baldock, Chief Admin & Dev Officer of Surgery Partners, Inc., reports acquiring 19,243 shares of restricted stock on February 28, 2024.

Summary

• On February 28, 2024, Jennifer Baldock, Chief Admin & Dev Officer of Surgery Partners, Inc., acquired 19,243 shares of common stock.
• The acquisition was in the form of restricted stock awards (RSAs) granted on the same date.
• The price per share was $31.18.
• The RSAs vest in three equal annual installments starting on the first anniversary of the grant date.
• Following the transaction, Baldock directly owns 187,559 shares of Surgery Partners, Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The acquisition of restricted stock by an executive generally indicates confidence in the company's future, but it's a routine transaction.

Positives

• The acquisition of restricted stock by a key executive signals confidence in the company's future performance.

Future Outlook

The vesting schedule of the restricted stock awards suggests a multi-year commitment from the executive.

Industry Context

Executive stock ownership is a common practice in publicly traded companies to align management's interests with those of shareholders. Restricted stock awards are a typical component of executive compensation packages.

Comparison to Industry Standards

• Executive compensation packages often include a mix of salary, bonus, and equity-based compensation, such as restricted stock or stock options.
• The vesting schedule of three years is a fairly standard practice for restricted stock awards.
• Comparing the size of the grant to similar grants at comparable healthcare companies would provide further context.

Stakeholder Impact

• The increased stock ownership by a key executive could be viewed positively by shareholders.

Key Dates